Profound Medical Corp. PRN.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 871.00K | 2.86M | 3.68M | 1.22M | 650.00K |
| Total Other Revenue | 1.61M | 2.47M | 2.30M | 4.07M | 1.56M |
| Total Revenue | 2.48M | 5.34M | 5.98M | 5.29M | 2.21M |
| Cost of Revenue | 536.00K | 1.51M | 1.99M | 1.36M | 593.00K |
| Gross Profit | 1.95M | 3.83M | 3.99M | 3.93M | 1.62M |
| SG&A Expenses | 7.36M | 6.59M | 7.09M | 7.43M | 9.33M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.55M | 13.36M | 13.35M | 14.20M | 16.02M |
| Operating Income | -11.07M | -8.02M | -7.37M | -8.91M | -13.81M |
| Income Before Tax | -9.49M | -7.03M | -8.15M | -7.86M | -15.63M |
| Income Tax Expenses | 55.00K | 25.00K | 26.00K | 121.00K | 64.00K |
| Earnings from Continuing Operations | -9.54M | -7.05M | -8.18M | -7.98M | -15.70M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.54M | -7.05M | -8.18M | -7.98M | -15.70M |
| EBIT | -11.07M | -8.02M | -7.37M | -8.91M | -13.81M |
| EBITDA | -10.93M | -7.92M | -7.26M | -8.77M | -13.67M |
| EPS Basic | -0.26 | -0.19 | -0.27 | -0.27 | -0.52 |
| Normalized Basic EPS | -0.16 | -0.12 | -0.17 | -0.16 | -0.33 |
| EPS Diluted | -0.26 | -0.19 | -0.27 | -0.27 | -0.52 |
| Normalized Diluted EPS | -0.16 | -0.12 | -0.17 | -0.16 | -0.33 |
| Average Basic Shares Outstanding | 36.35M | 36.30M | 30.73M | 30.10M | 30.05M |
| Average Diluted Shares Outstanding | 36.35M | 36.30M | 30.73M | 30.10M | 30.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |